"[6DF57088C00D]" . "According to Health Organization (WHO) adherence is defined as the extent to which the patients behaviour \u2013 taking medication, following a diet, and/or executing lifestyle changes \u2013 corresponds with agreed recommendations from a healthcare provider. High level of adherence is necessary in the treatment of chronic diseases. Following article deals with adherence in the treatment of multiple sclerosis, especially focusing on the disease modifying drugs of first choice, that are all injections, and need to be taken long term and regularly. Some methods, how to measure adherence are discussed, as well as factors leading to non-adherence and some recommendations how to increase adherence. It is necessary to support adherence all the time in everyday clinical practice. Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments."@en . . . . "3" . . "1"^^ . "1213-1814" . "121097" . . "CZ - \u010Cesk\u00E1 republika" . "multiple sclerosis; adherence; disease modifying drugs; injections"@en . . . . . . "1"^^ . . "RIV/00843989:_____/12:00102474" . "Adherence k l\u00E9\u010Db\u011B u roztrou\u0161en\u00E9 skler\u00F3zy" . . "V" . "Neurologie pro praxi" . "13" . "Hrad\u00EDlek, Pavel" . "RIV/00843989:_____/12:00102474!RIV13-MZ0-00843989" . "Adherence k l\u00E9\u010Db\u011B u roztrou\u0161en\u00E9 skler\u00F3zy"@cs . "Adherence k l\u00E9\u010Db\u011B u roztrou\u0161en\u00E9 skler\u00F3zy"@cs . "4"^^ . . "Adherence to treatment in multiple sclerosis"@en . . . "Adherence to treatment in multiple sclerosis"@en . "Adherence k l\u00E9\u010Db\u011B u roztrou\u0161en\u00E9 skler\u00F3zy" . . "Podle Sv\u011Btov\u00E9 zdravotnick\u00E9 organizace (WHO) je adherence definov\u00E1na jako rozsah, ve kter\u00E9m se pacientovo chov\u00E1n\u00ED (u\u017E\u00EDv\u00E1n\u00ED l\u00E9\u010Div, dodr\u017Eov\u00E1n\u00ED re\u017Eimov\u00FDch opat\u0159en\u00ED) shoduje s doporu\u010Den\u00EDmi poskytovatele zdravotn\u00ED p\u00E9\u010De nebo s l\u00E9\u010Debn\u00FDmi standardy. Vysok\u00E1 m\u00EDra adherence je nezbytn\u00E1 zvl\u00E1\u0161t\u011B p\u0159i l\u00E9\u010Db\u011B chronick\u00FDch onemocn\u011Bn\u00ED. N\u00E1sleduj\u00EDc\u00ED text pojedn\u00E1v\u00E1 o adherenci k l\u00E9\u010Db\u011B u nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED (RS), zvl\u00E1\u0161t\u011B se zam\u011B\u0159en\u00EDm na l\u00E9ky prvn\u00ED volby (tzv. DMD), kter\u00E9 jsou injek\u010Dn\u00ED a je nutno je aplikovat pravideln\u011B a dlouhodob\u011B. Jsou uvedeny n\u011Bkter\u00E9 metody, kter\u00FDmi je mo\u017Eno adherenci m\u011B\u0159it, faktory, kter\u00E9 ji sni\u017Euj\u00ED, a naopak zp\u016Fsoby, jak doc\u00EDlit jej\u00EDho zv\u00FD\u0161en\u00ED. V b\u011B\u017En\u00E9 klinick\u00E9 praxi je nutno adherenci neust\u00E1le podporovat. Jak\u00E9koli zv\u00FD\u0161en\u00ED efektivity proces\u016F a faktor\u016F ovliv\u0148uj\u00EDc\u00EDch adherenci k jednotliv\u00FDm terapeutick\u00FDm postup\u016Fm m\u016F\u017Ee m\u00EDt mnohem v\u011Bt\u0161\u00ED dopad na zdrav\u00ED populace ne\u017E jak\u00E9koli zlep\u0161en\u00ED jednotliv\u00FDch medic\u00EDnsk\u00FDch postup\u016F (Haynes et al., 2005)." . "Podle Sv\u011Btov\u00E9 zdravotnick\u00E9 organizace (WHO) je adherence definov\u00E1na jako rozsah, ve kter\u00E9m se pacientovo chov\u00E1n\u00ED (u\u017E\u00EDv\u00E1n\u00ED l\u00E9\u010Div, dodr\u017Eov\u00E1n\u00ED re\u017Eimov\u00FDch opat\u0159en\u00ED) shoduje s doporu\u010Den\u00EDmi poskytovatele zdravotn\u00ED p\u00E9\u010De nebo s l\u00E9\u010Debn\u00FDmi standardy. Vysok\u00E1 m\u00EDra adherence je nezbytn\u00E1 zvl\u00E1\u0161t\u011B p\u0159i l\u00E9\u010Db\u011B chronick\u00FDch onemocn\u011Bn\u00ED. N\u00E1sleduj\u00EDc\u00ED text pojedn\u00E1v\u00E1 o adherenci k l\u00E9\u010Db\u011B u nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED (RS), zvl\u00E1\u0161t\u011B se zam\u011B\u0159en\u00EDm na l\u00E9ky prvn\u00ED volby (tzv. DMD), kter\u00E9 jsou injek\u010Dn\u00ED a je nutno je aplikovat pravideln\u011B a dlouhodob\u011B. Jsou uvedeny n\u011Bkter\u00E9 metody, kter\u00FDmi je mo\u017Eno adherenci m\u011B\u0159it, faktory, kter\u00E9 ji sni\u017Euj\u00ED, a naopak zp\u016Fsoby, jak doc\u00EDlit jej\u00EDho zv\u00FD\u0161en\u00ED. V b\u011B\u017En\u00E9 klinick\u00E9 praxi je nutno adherenci neust\u00E1le podporovat. Jak\u00E9koli zv\u00FD\u0161en\u00ED efektivity proces\u016F a faktor\u016F ovliv\u0148uj\u00EDc\u00EDch adherenci k jednotliv\u00FDm terapeutick\u00FDm postup\u016Fm m\u016F\u017Ee m\u00EDt mnohem v\u011Bt\u0161\u00ED dopad na zdrav\u00ED populace ne\u017E jak\u00E9koli zlep\u0161en\u00ED jednotliv\u00FDch medic\u00EDnsk\u00FDch postup\u016F (Haynes et al., 2005)."@cs .